Results 271 to 280 of about 2,796,719 (361)

Bee Better: The Role of Honey in Modern Wound Care

Advanced Therapeutics, EarlyView.
The use of honey as a wound care agent is controversial but paradoxically increasingly popular. Honey possesses relevant antimicrobial properties and can modulate the immune system. The wound healing properties of honey likely depend on its composition and varies across wound types.
Léo‐Paul Tricou, Natalie Guirguis, Sarah Djebbar, Benjamin R. Freedman, Simon Matoori   +4 more
wiley   +1 more source

Emerging Immunotherapies for Disease Modification of Type 1 Diabetes. [PDF]

Drugs
Foster TP, Bruggeman BS, Haller MJ.
europepmc   +1 more source

Mining the virome for insights into type 1 diabetes [PDF]

, 2018
Park, Arnold, Zhao, Guoyan
core   +2 more sources

Retrospective validation of a physiological model of glucose-insulin interaction in type 1 diabetes mellitus

, 1994
Eldon D. Lehmann, I. Hermanyi, Tibor Deutsch   +2 more
openalex   +1 more source

Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study [PDF]

, 1999
María J. Redondo, Marian Rewers, Liping Yu, Satish K. Garg, C.C. Pilcher, Robert B. Elliott, George S. Eisenbarth   +6 more
openalex   +1 more source

Enhanced Epithelial Cell Uptake of Glycol Chitosan‐Coated PLGA Nanoparticles for Oral Drug Delivery

Advanced Therapeutics, EarlyView.
Here, glycol chitosan (GC)‐coated PLGA NPs are developed to enhance oral drug delivery by enabling dual‐pathway endocytosis via clathrin‐ and caveolae‐mediated mechanisms. Alginate layering coating on GC‐PLGA further improves oral insulin delivery, achieving sustained glucose reduction in diabetic mice.
Huiwen Pang, Wenxuan Yu, Youzhi Wu, Xuqiang Nie, Guojun Huang, Zhi Ping Xu, Chen Chen, Felicity Y. Han   +7 more
wiley   +1 more source

Targeting B-cell subsets in type 1 diabetes: possible routes to therapy? [PDF]

EBioMedicine
Morgan NG.
europepmc   +1 more source

Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled Study¹ [PDF]

, 1998
Vivian Fonseca, Thomas R. Valiquett, Saling M. Huang, Mahmoud N. Ghazzi, Randall W. Whitcomb   +4 more
openalex   +1 more source

On the Relentless Pursuit of an Oral Insulin Delivery System: How Far is Too Far?

Advanced Therapeutics, EarlyView.
Injectable insulin preparations have far outpaced oral ones by virtue of adequate bioavailability and are driven by innovations, including insulin pumps, real‐time blood glucose monitoring, and artificial intelligence. In contrast, oral insulin delivery systems, including nanomedicines, continue to struggle and lag due to varied reasons.
Sourav Bhattacharjee
wiley   +1 more source

Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. [PDF]

, 1998
Charles F. Verge, Pnina Vardi, Sunanda Babu, Fei Bao, M Kellis, T.L. Bugawan, Dov Tiosano, Ling Yu, George S. Eisenbarth, Pamela R. Fain   +9 more
openalex   +1 more source